Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04083950 · ClinicalTrials.gov registry record · Early Phase 1
Induction of Gut Permeability by an Oral Vaccine
A Early Phase 1 study of Inflammation and Vaccine, sponsored by USDA, Western Human Nutrition Research Center.
- Active
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT04083950 is a Early Phase 1 study of Inflammation and Vaccine that is active but no longer recruiting, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 10 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04083950, a Early Phase 1 study of Inflammation and Vaccine, is active but no longer recruiting, sponsored by USDA, Western Human Nutrition Research Center.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effect of an oral typhoid vaccine on disruption of the intestinal barrier and response of the immune system. Intestinal and whole-body responses will be measured in all participants before and after the vaccine.
Conditions Studied
Interventions
- BIOLOGICAL Vivotif Typhoid Oral Vaccine
- DRUG Aspirin (Positive Control)
Study Locations (1)
California
- USDA, ARS, Western Human Nutrition Research Center - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-12-04 |
| Est. Completion | 2026-09-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04083950
The ClinicalTrials.gov registry entry for NCT04083950 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (97% lower). The listed sponsor is USDA, Western Human Nutrition Research Center, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Vivotif Typhoid Oral Vaccine is the first listed.
NCT04083950 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04083950 about?
NCT04083950 is a clinical study titled "Induction of Gut Permeability by an Oral Vaccine". This study evaluates the effect of an oral typhoid vaccine on disruption of the intestinal barrier and response of the immune system. Intestinal and whole-body responses will be measured in all participants before and after the vaccine.
What is the current status of trial NCT04083950?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2019-12-04. Estimated completion is 2026-09-30.
What conditions does trial NCT04083950 study?
This clinical trial studies the following conditions: Inflammation, Vaccine, Intestinal Permeability, Typhoid Fever.
What interventions are being tested in trial NCT04083950?
The interventions under investigation include: Vivotif Typhoid Oral Vaccine (BIOLOGICAL), Aspirin (Positive Control) (DRUG).
Who is sponsoring clinical trial NCT04083950?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04083950 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use
RECRUITING · Early Phase 1
-
Sleep and Inflammatory Resolution Pathway
ACTIVE NOT RECRUITING · Early Phase 1
-
Effect of High-Legume Diet on Colorectal Cancer Risk
COMPLETED · Early Phase 1
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Reducing Frailty for Older Cancer Survivors Using Supplements II
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.